On February 6, 2024 Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), reported that Bill Newell, Chief Executive Officer, will participate in three upcoming investor conferences (Press release, Sutro Biopharma, FEB 6, 2024, View Source [SID1234639886]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Details:
Oppenheimer 34th Annual Healthcare Life Sciences Conference
Date: February 13-14, 2024
Location: Virtual
TD Cowen 44th Annual Health Care Conference
Date: March 3-6, 2024
Location: Boston
Barclays 26th Annual Global Healthcare Conference
Date: March 12-14, 2024
Location: Miami
Webcasts of the presentations will be accessible through the News & Events page of the Investor Relations section of the company’s website at www.sutrobio.com. Archived replays will be available for at least 30 days after the event.